The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Image-guided Biopsy-Global Market Insights and Sales Trends 2024
Synopsis
Image-guided biopsy makes the use of imaging technologies in order to analyze the inside of the body. They utilized MIR, CT, ultrasound and x-ray for this procedure. The biopsy assists the medical professional to get the sample of the suspicious cell easily through the insertion of the needle into the best position. It is considered one of the best ways to collect samples as it causes no unnecessary injuries.
The global Image-guided Biopsy market size is expected to reach US$ 1652.7 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Image-guided Biopsy in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centers, Clinics and Others, are propelling Image-guided Biopsy market. X- Ray, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ultrasound segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Image-guided Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Image-guided Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Image-guided Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Image-guided Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Image-guided Biopsy covered in this report include Koninklijke Philips, Siemens Healthcare, Analogic Corporation, General Electric, Varian Medical Systems, Brainlab, Medtronic, Olympus Corporation and KARL STORZ Endoscopy India, etc.
The global Image-guided Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker
Global Image-guided Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Image-guided Biopsy market, Segment by Type:
X- Ray
Ultrasound
Mammograpy
CT
MRI
Others
Global Image-guided Biopsy market, by Application
Hospitals
Ambulatory Surgery Centers
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Image-guided Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Image-guided biopsy makes the use of imaging technologies in order to analyze the inside of the body. They utilized MIR, CT, ultrasound and x-ray for this procedure. The biopsy assists the medical professional to get the sample of the suspicious cell easily through the insertion of the needle into the best position. It is considered one of the best ways to collect samples as it causes no unnecessary injuries.
The global Image-guided Biopsy market size is expected to reach US$ 1652.7 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Image-guided Biopsy in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centers, Clinics and Others, are propelling Image-guided Biopsy market. X- Ray, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ultrasound segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Image-guided Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Image-guided Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Image-guided Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Image-guided Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Image-guided Biopsy covered in this report include Koninklijke Philips, Siemens Healthcare, Analogic Corporation, General Electric, Varian Medical Systems, Brainlab, Medtronic, Olympus Corporation and KARL STORZ Endoscopy India, etc.
The global Image-guided Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker
Global Image-guided Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Image-guided Biopsy market, Segment by Type:
X- Ray
Ultrasound
Mammograpy
CT
MRI
Others
Global Image-guided Biopsy market, by Application
Hospitals
Ambulatory Surgery Centers
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Image-guided Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Image-guided Biopsy
1.1 Image-guided Biopsy Market Overview
1.1.1 Image-guided Biopsy Product Scope
1.1.2 Image-guided Biopsy Market Status and Outlook
1.2 Global Image-guided Biopsy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Image-guided Biopsy Market Size by Region (2018-2029)
1.4 Global Image-guided Biopsy Historic Market Size by Region (2018-2023)
1.5 Global Image-guided Biopsy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Image-guided Biopsy Market Size (2018-2029)
1.6.1 North America Image-guided Biopsy Market Size (2018-2029)
1.6.2 Europe Image-guided Biopsy Market Size (2018-2029)
1.6.3 Asia-Pacific Image-guided Biopsy Market Size (2018-2029)
1.6.4 Latin America Image-guided Biopsy Market Size (2018-2029)
1.6.5 Middle East & Africa Image-guided Biopsy Market Size (2018-2029)
2 Image-guided Biopsy Market by Type
2.1 Introduction
2.1.1 X- Ray
2.1.2 Ultrasound
2.1.3 Mammograpy
2.1.4 CT
2.1.5 MRI
2.1.6 Others
2.2 Global Image-guided Biopsy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Image-guided Biopsy Historic Market Size by Type (2018-2023)
2.2.2 Global Image-guided Biopsy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Image-guided Biopsy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Image-guided Biopsy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Image-guided Biopsy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Image-guided Biopsy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Image-guided Biopsy Revenue Breakdown by Type (2018-2029)
3 Image-guided Biopsy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgery Centers
3.1.3 Clinics
3.1.4 Others
3.2 Global Image-guided Biopsy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Image-guided Biopsy Historic Market Size by Application (2018-2023)
3.2.2 Global Image-guided Biopsy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Image-guided Biopsy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Image-guided Biopsy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Image-guided Biopsy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Image-guided Biopsy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Image-guided Biopsy Revenue Breakdown by Application (2018-2029)
4 Image-guided Biopsy Competition Analysis by Players
4.1 Global Image-guided Biopsy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Image-guided Biopsy as of 2022)
4.3 Date of Key Players Enter into Image-guided Biopsy Market
4.4 Global Top Players Image-guided Biopsy Headquarters and Area Served
4.5 Key Players Image-guided Biopsy Product Solution and Service
4.6 Competitive Status
4.6.1 Image-guided Biopsy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Koninklijke Philips
5.1.1 Koninklijke Philips Profile
5.1.2 Koninklijke Philips Main Business
5.1.3 Koninklijke Philips Image-guided Biopsy Products, Services and Solutions
5.1.4 Koninklijke Philips Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.1.5 Koninklijke Philips Recent Developments
5.2 Siemens Healthcare
5.2.1 Siemens Healthcare Profile
5.2.2 Siemens Healthcare Main Business
5.2.3 Siemens Healthcare Image-guided Biopsy Products, Services and Solutions
5.2.4 Siemens Healthcare Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens Healthcare Recent Developments
5.3 Analogic Corporation
5.3.1 Analogic Corporation Profile
5.3.2 Analogic Corporation Main Business
5.3.3 Analogic Corporation Image-guided Biopsy Products, Services and Solutions
5.3.4 Analogic Corporation Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.3.5 General Electric Recent Developments
5.4 General Electric
5.4.1 General Electric Profile
5.4.2 General Electric Main Business
5.4.3 General Electric Image-guided Biopsy Products, Services and Solutions
5.4.4 General Electric Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.4.5 General Electric Recent Developments
5.5 Varian Medical Systems
5.5.1 Varian Medical Systems Profile
5.5.2 Varian Medical Systems Main Business
5.5.3 Varian Medical Systems Image-guided Biopsy Products, Services and Solutions
5.5.4 Varian Medical Systems Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.5.5 Varian Medical Systems Recent Developments
5.6 Brainlab
5.6.1 Brainlab Profile
5.6.2 Brainlab Main Business
5.6.3 Brainlab Image-guided Biopsy Products, Services and Solutions
5.6.4 Brainlab Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.6.5 Brainlab Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic Image-guided Biopsy Products, Services and Solutions
5.7.4 Medtronic Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic Recent Developments
5.8 Olympus Corporation
5.8.1 Olympus Corporation Profile
5.8.2 Olympus Corporation Main Business
5.8.3 Olympus Corporation Image-guided Biopsy Products, Services and Solutions
5.8.4 Olympus Corporation Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.8.5 Olympus Corporation Recent Developments
5.9 KARL STORZ Endoscopy India
5.9.1 KARL STORZ Endoscopy India Profile
5.9.2 KARL STORZ Endoscopy India Main Business
5.9.3 KARL STORZ Endoscopy India Image-guided Biopsy Products, Services and Solutions
5.9.4 KARL STORZ Endoscopy India Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.9.5 KARL STORZ Endoscopy India Recent Developments
5.10 Stryker
5.10.1 Stryker Profile
5.10.2 Stryker Main Business
5.10.3 Stryker Image-guided Biopsy Products, Services and Solutions
5.10.4 Stryker Image-guided Biopsy Revenue (US$ Million) & (2018-2023)
5.10.5 Stryker Recent Developments
6 North America
6.1 North America Image-guided Biopsy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Image-guided Biopsy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Image-guided Biopsy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Image-guided Biopsy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Image-guided Biopsy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Image-guided Biopsy Market Dynamics
11.1 Image-guided Biopsy Industry Trends
11.2 Image-guided Biopsy Market Drivers
11.3 Image-guided Biopsy Market Challenges
11.4 Image-guided Biopsy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
